T3	intervention 843 861	adjuvant tamoxifen
T4	control 872 899	adjuvant systemic treatment
T5	eligibility 903 922	premenopausal women
T7	total-participants 943 946	564
T8	location 982 988	Sweden
T9	intervention-participants 1220 1223	390
T10	intervention-participants 1248 1251	390
T11	intervention-participants 1286 1289	361
T12	outcome 1337 1364	prevalence of ER-positivity
T13	iv-bin-percent 1386 1389	75%
T14	iv-bin-percent 1394 1397	72%
T15	iv-bin-percent 1418 1421	68%
T16	iv-bin-percent 1426 1429	66%
T17	iv-bin-percent 1444 1447	66%
T18	iv-bin-percent 1452 1455	62%
